Highlights and Quick Summary
- Financing cash flow for the quarter ending December 31, 2022 was $-39.3 Million (a -66.06% decrease compared to previous quarter)
- Year-over-year quarterly Financing cash flow increased by 23999.39%
- Annual Financing cash flow for 2022 was $-155 Million (a -228.14% decrease from previous year)
- Annual Financing cash flow for 2021 was $121 Million (a 270.55% increase from previous year)
- Annual Financing cash flow for 2020 was $32.7 Million (a 301.88% increase from previous year)
- Twelve month Financing cash flow ending December 31, 2022 was $-155 Million (a 33.73% increase compared to previous quarter)
- Twelve month trailing Financing cash flow increased by 970475.0% year-over-year
Trailing Financing cash flow for the last four month:
| 31 Dec '22 | 30 Sep '22 | 30 Jun '22 | 31 Mar '22 |
|---|---|---|---|
| $-155 Million | $-116 Million | $-152 Thousand | $-16 Thousand |
Visit stockrow.com/PGEN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Financing cash flow of Precigen, Inc.
Most recent Financing cash flowof PGEN including historical data for past 10 years.Interactive Chart of Financing cash flow of Precigen, Inc.
Precigen, Inc. Financing cash flow for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | $-39.28 | $-115.73 | $-0.11 | $-0.16 | $-155.29 |
| 2021 | $-0.11 | $0.23 | $0.02 | $121.04 | $121.19 |
| 2020 | $-0.07 | $-0.11 | $-1.26 | $34.15 | $32.71 |
| 2019 | $1.2 | $0.05 | $-0.03 | $6.93 | $8.14 |
| 2018 | $27.25 | $193.6 | $0.68 | $88.26 | $309.8 |
| 2017 | $13.7 | $-6.68 | $0.41 | $-3.15 | $4.28 |
| 2016 | $0.9 | $-5.72 | $7.29 | $9.59 | $12.07 |
| 2015 | $0.24 | $213.05 | $7.73 | $110.66 | $331.68 |
| 2014 | $1.41 | $-3.38 | $0.76 | $25.21 | $24.0 |
| 2013 | $0.47 | $169.0 | $83.91 | $63.07 | $316.45 |
| 2012 | $25.2 | $0.2 | $50.55 | – | $75.94 |
Business Profile of Precigen, Inc.
Sector: Healthcare
Industry: Biotechnology